37
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders.

      Lancet Neurology
      Animals, Epilepsy, drug therapy, metabolism, Humans, Nervous System Diseases, Sodium Channel Blockers, therapeutic use, Sodium Channels

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Voltage-gated sodium channels (VGSCs) are key mediators of intrinsic neuronal and muscle excitability. Abnormal VGSC activity is central to the pathophysiology of epileptic seizures, and many of the most widely used antiepileptic drugs, including phenytoin, carbamazepine, and lamotrigine, are inhibitors of VGSC function. These antiepileptic drugs might also be efficacious in the treatment of other nervous system disorders, such as migraine, multiple sclerosis, neurodegenerative diseases, and neuropathic pain. In this Review, we summarise the structure and function of VGSCs and their involvement in the pathophysiology of several neurological disorders. We also describe the biophysical and molecular bases for the mechanisms of action of antiepileptic VGSC blockers and discuss the efficacy of these drugs in the treatment of epileptic and non-epileptic disorders. Overall, clinical and experimental data indicate that these drugs are efficacious for a range of diseases, and that the development of drugs with enhanced selectivity for specific VGSC isoforms might be an effective and novel approach for the treatment of several neurological diseases. 2010 Elsevier Ltd. All rights reserved.

          Related collections

          Author and article information

          Journal
          20298965
          10.1016/S1474-4422(10)70059-4

          Chemistry
          Animals,Epilepsy,drug therapy,metabolism,Humans,Nervous System Diseases,Sodium Channel Blockers,therapeutic use,Sodium Channels

          Comments

          Comment on this article